Kristina will discuss the differences in supply, sourcing, dosing flexibility, and cost so you can choose with full information
Regular check-ins and blood tests play a key role in finding the right dose
GLP-1 plays a key role in the occurrence and development of metabolic diseases such as obesity, nonalcoholic fatty liver disease, and atherosclerosis by regulating lipid metabolism
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has shown superior efficacy in glycemic control, weight loss and cardiometabolic outcomes compared to GLP-1 agonists alone
Patent status: data exclusivity expired Jan 4, 2026
Most protocols recommend 2-3 hours after eating, with sleep following within 30-60 minutes